Jennifer Giandhari

13.5k total citations
30 papers, 446 citations indexed

About

Jennifer Giandhari is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Jennifer Giandhari has authored 30 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 13 papers in Virology and 8 papers in Epidemiology. Recurrent topics in Jennifer Giandhari's work include HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (13 papers) and HIV/AIDS Research and Interventions (11 papers). Jennifer Giandhari is often cited by papers focused on HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (13 papers) and HIV/AIDS Research and Interventions (11 papers). Jennifer Giandhari collaborates with scholars based in South Africa, United States and United Kingdom. Jennifer Giandhari's co-authors include Túlio de Oliveira, Houriiyah Tegally, James Emmanuel San, Richard Lessells, Benjamin Chimukangara, Eduan Wilkinson, Lavanya Singh, Sureshnee Pillay, Maryam Fish and Khulekani Sedwell Khanyile and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jennifer Giandhari

27 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer Giandhari South Africa 12 298 125 107 73 38 30 446
Monica Tolazzi Italy 8 279 0.9× 164 1.3× 117 1.1× 85 1.2× 19 0.5× 17 502
Joshua A. Weiner United States 13 245 0.8× 87 0.7× 125 1.2× 109 1.5× 12 0.3× 27 539
D Fischer United States 8 107 0.4× 116 0.9× 98 0.9× 72 1.0× 38 1.0× 15 310
Joseph P. Shott United States 10 123 0.4× 72 0.6× 66 0.6× 56 0.8× 16 0.4× 16 302
Stefan Schmutz Switzerland 11 141 0.5× 66 0.5× 147 1.4× 120 1.6× 85 2.2× 17 379
Qingrui Huang China 12 246 0.8× 44 0.4× 150 1.4× 154 2.1× 10 0.3× 23 514
Mary E. Petrone United States 8 208 0.7× 63 0.5× 42 0.4× 37 0.5× 17 0.4× 17 291
Cornelius Roemer Switzerland 5 555 1.9× 41 0.3× 237 2.2× 112 1.5× 83 2.2× 6 679
Prudence Kgagudi South Africa 7 685 2.3× 27 0.2× 185 1.7× 92 1.3× 31 0.8× 10 797

Countries citing papers authored by Jennifer Giandhari

Since Specialization
Citations

This map shows the geographic impact of Jennifer Giandhari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Giandhari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Giandhari more than expected).

Fields of papers citing papers by Jennifer Giandhari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Giandhari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Giandhari. The network helps show where Jennifer Giandhari may publish in the future.

Co-authorship network of co-authors of Jennifer Giandhari

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Giandhari. A scholar is included among the top collaborators of Jennifer Giandhari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Giandhari. Jennifer Giandhari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tshiabuila, Derek, Wonderful T. Choga, James Emmanuel San, et al.. (2024). An Oxford Nanopore Technology-Based Hepatitis B Virus Sequencing Protocol Suitable for Genomic Surveillance Within Clinical Diagnostic Settings. International Journal of Molecular Sciences. 25(21). 11702–11702. 1 indexed citations
2.
Egger, Matthias, Stefanie Hossmann, Niko Beerenwinkel, et al.. (2024). HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre study (DTG RESIST). BMJ Open. 14(8). e085819–e085819. 1 indexed citations
3.
McCluskey, Suzanne M., Winnie Muyindike, Ashley Stuckwisch, et al.. (2024). Population Effectiveness of Dolutegravir Implementation in Uganda: A Prospective Observational Cohort Study (DISCO), 48-Week Results. The Journal of Infectious Diseases. 230(3). e622–e630. 6 indexed citations
4.
Chohan, Bhavna, Brandon L. Guthrie, Eduan Wilkinson, et al.. (2023). Virologic Nonsuppression and HIV Drug Resistance Among People Who Inject Drugs and Their Sexual and Injecting Partners in Kenya. AIDS Research and Human Retroviruses. 40(5). 240–250.
5.
Mvelase, Nomonde R., Ravesh Singh, Yeshnee Naidoo, et al.. (2023). Consequences of rpoB mutations missed by the GenoType MTBDRplus assay in a programmatic setting in South Africa. African Journal of Laboratory Medicine. 12(1). 1975–1975. 7 indexed citations
6.
Subramoney, Kathleen, Jennifer Giandhari, Houriiyah Tegally, et al.. (2023). SARS-CoV-2 spike protein diversity at an intra-host level, among SARS-CoV-2 infected individuals in South Africa, 2020 to 2022. PLoS ONE. 18(5). e0286373–e0286373. 3 indexed citations
7.
Subramoney, Kathleen, Jennifer Giandhari, Yeshnee Naidoo, et al.. (2023). Molecular Epidemiology of SARS-CoV-2 during Five COVID-19 Waves and the Significance of Low-Frequency Lineages. Viruses. 15(5). 1194–1194. 4 indexed citations
8.
Tshiabuila, Derek, Jennifer Giandhari, Sureshnee Pillay, et al.. (2022). Comparison of SARS-CoV-2 sequencing using the ONT GridION and the Illumina MiSeq. BMC Genomics. 23(1). 24 indexed citations
9.
Msomi, Nokukhanya, Raveen Parboosing, Eduan Wilkinson, et al.. (2022). Persistent Hepatitis B Viraemia with Polymerase Mutations among HIV/HBV Co-Infected Patients on HBV-Active ART in KwaZulu-Natal, South Africa. Viruses. 14(4). 788–788. 4 indexed citations
10.
Ismael, Nália, Eduan Wilkinson, Jennifer Giandhari, et al.. (2022). Molecular Epidemiology and Trends in HIV-1 Transmitted Drug Resistance in Mozambique 1999–2018. Viruses. 14(9). 1992–1992. 9 indexed citations
11.
Singh, Lavanya, James Emmanuel San, Houriiyah Tegally, et al.. (2022). Targeted Sanger sequencing to recover key mutations in SARS-CoV-2 variant genome assemblies produced by next-generation sequencing. Microbial Genomics. 8(3). 3 indexed citations
12.
San, James Emmanuel, Sinaye Ngcapu, Aquillah M. Kanzi, et al.. (2021). Transmission dynamics of SARS-CoV-2 within-host diversity in two major hospital outbreaks in South Africa. Virus Evolution. 7(1). veab041–veab041. 28 indexed citations
13.
Chimukangara, Benjamin, Richard Lessells, Benn Sartorius, et al.. (2021). HIV-1 drug resistance in adults and adolescents on protease inhibitor-based antiretroviral therapy in KwaZulu-Natal Province, South Africa. Journal of Global Antimicrobial Resistance. 29. 468–475. 12 indexed citations
14.
San, James Emmanuel, Farzana Osman, Nigel Garrett, et al.. (2021). Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis. Frontiers in Immunology. 12. 730986–730986. 35 indexed citations
15.
Siedner, Mark J., Michelle Moorhouse, Bryony Simmons, et al.. (2020). Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase. Nature Communications. 11(1). 5922–5922. 59 indexed citations
16.
Pillay, Sureshnee, Jennifer Giandhari, Houriiyah Tegally, et al.. (2020). Whole Genome Sequencing of SARS-CoV-2: Adapting Illumina Protocols for Quick and Accurate Outbreak Investigation during a Pandemic. Genes. 11(8). 949–949. 50 indexed citations
17.
Giandhari, Jennifer, Sureshnee Pillay, Eduan Wilkinson, et al.. (2020). Early transmission of SARS-CoV-2 in South Africa: An epidemiological and phylogenetic report. International Journal of Infectious Diseases. 103. 234–241. 59 indexed citations
18.
Tegally, Houriiyah, James Emmanuel San, Jennifer Giandhari, & Túlio de Oliveira. (2020). Unlocking the efficiency of genomics laboratories with robotic liquid-handling. BMC Genomics. 21(1). 729–729. 54 indexed citations
19.
Giandhari, Jennifer, Adriaan E. Basson, Chris M. Parry, et al.. (2016). Contribution of Gag and Protease to HIV-1 Phenotypic Drug Resistance in Pediatric Patients Failing Protease Inhibitor-Based Therapy. Antimicrobial Agents and Chemotherapy. 60(4). 2248–2256. 14 indexed citations
20.
Giandhari, Jennifer, Adriaan E. Basson, Ashraf Coovadia, et al.. (2015). Genetic Changes in HIV-1 Gag-Protease Associated with Protease Inhibitor-Based Therapy Failure in Pediatric Patients. AIDS Research and Human Retroviruses. 31(8). 776–782. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monica Tolazzi Breakdown of academic impact, for papers by Joshua A. Weiner Breakdown of academic impact, for papers by D Fischer Breakdown of academic impact, for papers by Joseph P. Shott Breakdown of academic impact, for papers by Stefan Schmutz Breakdown of academic impact, for papers by Qingrui Huang Breakdown of academic impact, for papers by Mary E. Petrone Breakdown of academic impact, for papers by Cornelius Roemer Breakdown of academic impact, for papers by Prudence Kgagudi
Rankless by CCL
2026